Related Experiment Video
Updated: Jul 15, 2026
10:21
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1-C/EBPalpha interaction
T Fujimoto1, K Anderson, S E W Jacobsen
1EMBL Mouse Biology Unit, Monterotondo, Italy.
The EMBO Journal
|April 14, 2007
Summary
Cyclin-dependent kinase 6 (Cdk6) inhibits myeloid progenitor differentiation by blocking the transcription factor Runx1. Downregulation of Cdk6 releases Runx1, enabling terminal differentiation in hematopoietic cells.
Area of Science:
- Cell Biology
- Molecular Biology
- Hematopoiesis
Background:
- Cell cycle regulators and transcription factors coordinate cell proliferation and differentiation.
- Hematopoietic progenitor cells undergo tightly regulated proliferation and differentiation processes.
Purpose of the Study:
- To investigate the role of cyclin-dependent kinase 6 (Cdk6) in regulating hematopoietic progenitor cell differentiation.
- To elucidate the molecular mechanism by which Cdk6 influences transcription factor activity and lineage commitment.
Main Methods:
- Western blotting and immunohistochemistry to detect Cdk6 expression in hematopoietic progenitor cells.
- Co-immunoprecipitation assays to assess protein-protein interactions between Cdk6 and transcription factors.
- In vitro and in vivo assays to evaluate the effects of Cdk6 on myeloid progenitor proliferation and differentiation.
- Reporter assays to measure transcriptional activation by Runx1.
Main Results:
- Cdk6 is specifically expressed in proliferating hematopoietic progenitor cells.
- Cdk6 directly binds to Runx1, inhibiting its DNA binding and interaction with C/EBPalpha.
- Cdk6 expression promotes myeloid progenitor proliferation and suppresses myeloid lineage-specific gene expression and terminal differentiation.
- Cdk6's effects on differentiation are independent of its kinase activity and can be reversed by increased Runx1 levels.
Conclusions:
- Cdk6 acts as a novel inhibitor of Runx1-mediated transcriptional activation, thereby suppressing myeloid differentiation.
- Downregulation of Cdk6 in myeloid progenitors is crucial for releasing Runx1 inhibition and allowing terminal differentiation.
- This noncanonical function of Cdk6 in controlling differentiation may extend to other cell lineages where Runx factors are involved.
Related Concept Videos
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...